
Reset all filters
01 1Patheon Italia S.p.A.
Reset all filters
01 1caplacizumab
Reset all filters
01 1U.S.A
NDC Package Code : 68225-256
Start Marketing Date : 2019-02-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (11mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING